Developed in 1999 by Dr. Albert Kligman (discoverer of tretinoin), its Multi-Lamellar Emulsion (MLE®) technology reconstructs skin barriers by mimicking infant vernix caseosa. The Real Barrier Cream is used in 73% of Korean neonatal ICUs for premature infants. Manufacturing follows pharmaceutical-grade stability testing at ±40°C.